XRAY Stock Analysis: Buy, Sell, or Hold?
XRAY - DENTSPLY SIRONA Inc.
$10.98
0.20 (1.81%)
▲
5d:
+6.24%
30d:
+9.75%
90d:
-5.92%
BUY
MODERATE Confidence
Analysis Updated: Jun 25, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.4/10
Get Alerted When XRAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: XRAY shows positive signals but monitor for confirmation. Market pricing in 2.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: XRAY shows positive signals but monitor for confirmation. Market pricing in 2.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.84
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$9.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: XRAY is currently trading at $10.97, which is considered extended relative to its 30-day fair value range of $9.84 to $10.48. The stock's valuation (Forward PE: 7.0) is in line with its historical norms (7.5). Remarkably, the market is currently pricing in an annual earnings decline of 2.5% over the next few years. This pessimistic expectation contrasts with the company's recent 15.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, XRAY is in a strong downtrend. The price is approaching resistance at $10.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: XRAY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.40 (+24.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XRAY is in a strong downtrend. The price is approaching resistance at $10.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: XRAY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.40 (+24.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.84 -
$10.48
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.3% below Wall St target ($13.40)
Trading Range Analysis
30-Day Trading Range
$9.84 -
$10.48
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.75
Resistance Level
$10.98
Current Trend
Strong Downtrend
Technical data as of
Jun 25, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.97
Wall Street Target
$13.40
(+24.3%)
Revenue Growth (YoY)
0.1%
Earnings Growth (YoY)
15.2%
Profit Margin
-17.1%
Valuation Discount vs History
-2.5% cheaper
PE vs Historical
7.0 vs 7.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.5%
(market-implied from PE analysis)
1-Year Target
$10.51
(-3%)
2-Year Target
$10.25
(-5%)
3-Year Target
$9.99
(-7%)
3-Yr Target (if PE normalizes)
(PE: 7→8)
$10.75
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.9%)
$43.48
(+303%)
Base:
(SPY PE: 7.0, Growth: 8.9%)
$13.92
(+29%)
Bear:
(PE: 5.9, Growth: 8.9%)
$11.83
(+10%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.0 to 7.5
Stabilization Target:
$11.60
(+7.6%)
PE Expansion Potential:
+7.6%
Share & Embed Analysis
Last updated: June 26, 2026 12:05 PM ET
Data refreshes hourly during market hours. Next update: 1:05 PM
Data refreshes hourly during market hours. Next update: 1:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XRAY showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gregory T Lucier
BUY
15000 shares
2026-03-09
James D Forbes
BUY
5000 shares
2026-03-09
Gregory T Lucier
BUY
22445 shares
2026-03-03
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 59 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 67 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 65 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 53 HOLD |
Advanced XRAY Option Strategies
Professional options setups generated by AI based on today's XRAY price and gamma walls.
